DSpace JSPUI
DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets
Learn More
Browsing by Subject
Showing results 3032 to 3051 of 7641
< previous
next >
- systemic lupus erythematosus, anemia of chronic diseases, iron, iron-deficiency anemia, hemoglobin 1
- systemic lupus erythematosus, anemia of chronic diseases, iron, iron-deficiency anemia, hemoglobin. 1
- Systemic lupus erythematosus, atherosclerosis, cardiovascular risk factors 1
- Systemic lupus erythematosus, cardiac damage, pericarditis, myocarditis, endocarditis, antiphospholipid syndrome, myocardial infarction 1
- Systemic lupus erythematosus, endothelial dysfunction, vascular endothelial growth factor 2
- systemic lupus erythematosus, gouty arthritis, diagnosis, treatment 1
- systemic lupus erythematosus, hepatargia, autolysis of liver cells, early diagnosis 1
- systemic lupus erythematosus, hepatorrhia, autolysis ("liver death"), early diagnosis, criteria 1
- systemic lupus erythematosus, HIV-infection, differential diagnosis. 1
- systemic lupus erythematosus, kidney disease, tumor necrosis factor α, C-reactive protein 1
- Systemic Lupus Erythematosus; Atherosclerosis, Nontraditional Cardiovascular Risk Factors; Treatment 1
- systemic scleroderma, 25(OH)vitamin D3, calcium, osteoporosis, osteopenia, bone mineral density, densitometry 2
- Systemic Scleroderma, Atherosclerosis, Cardiovascular Risk Factors 1
- Systemic scleroderma, cardiovascular system, il-6, treatment, statins, tocilizumab. 1
- systemic scleroderma, fibrosis, treatment, ACE inhibitors 1
- systemic scleroderma, peripheral vascular damage, pulse therapy, remission. 1
- systemic scleroderma; sclerodermic renal crisis; vascular endothelial dysfunction; chronic sclerodermic nephropathy; nonimmune factors of nephropathy progression; chronic kidney disease. 1
- Systemic sclerosis, anti-nuclear antibodies, fibrillarin-(U3-RNP), AFA- anti-fibrillarin antibodies, Raynaud's phenomenon 1
- Systemic sclerosis, anti-nuclear antibodies, fibrillarin-(U3-RNP), AFA- anti-fibrillarin antibodies, Raynaud’s phenomenon. 1
- systemic sclerosis, intestinal tract, large intestine obstruction 1